Visa Stock May Be Fairly Valued Amidst Antitrust Scrutiny

Visa (V) stock has delivered impressive returns over the past five years, but current checks suggest it may no longer be clearly undervalued.

The company's intrinsic value estimate from the Excess Returns model is in line with its market price, while earnings-based multiples lean expensive.

A 66.7% return over the past five years frames Visa as a stock that has already rewarded patient holders, raising the bar for any new valuation upside.

Visa's strong profitability and growth initiatives, such as agentic payments partnerships and the Visa Platform Connect program, can support long-term volume and fee growth.

However, the ongoing US Department of Justice antitrust case may add valuation risk if it affects pricing power or business practices.